Terms: = Colorectal cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Prognosis
4021 results:
1. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract] [Full Text] [Related]
2. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
Ben-Yaacov A; Levine O; Schtrechman G; Adileh M; Beller T; Boursi B; Halpern N; Goldstein A; Ben-Yakov G; Nissan A; Laks S
World J Surg; 2024 Apr; 48(4):871-878. PubMed ID: 38686748
[TBL] [Abstract] [Full Text] [Related]
3. Long term survival outcomes of surgery combined with hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms: A multicenter retrospective study.
Han Z; Liu X; Tian Y; Shen S; Wang H; Hu S; Wu X; Yan Z; Lu C; Wang P; Bai Y; Kong Y; Wang L; Cao S; Li Z; Zhong H; Meng C; Zhou Y
World J Surg; 2024 Jan; 48(1):86-96. PubMed ID: 38686746
[TBL] [Abstract] [Full Text] [Related]
4. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
5. A novel classification of posterior pelvic exenteration to assess prognosis in female patients with locally advanced primary rectal cancer: a retrospective cohort study from China PelvEx collaborative.
Li Y; Zhuang M; Hu G; Zhang J; Qiu W; Mei S; Tang J
Int J Colorectal Dis; 2024 Apr; 39(1):59. PubMed ID: 38664256
[TBL] [Abstract] [Full Text] [Related]
6. Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.
Ulanja MB; Asafo-Agyei KO; Neelam V; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Ulanja RN; Nteim GB; Mabrouk T; Amankwah M; Alese OB
Cancer Med; 2024 Apr; 13(8):e7145. PubMed ID: 38651190
[TBL] [Abstract] [Full Text] [Related]
7. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
[No Abstract] [Full Text] [Related]
8. The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
Xu T; Feng L; Zhang W; Li H; Ma H; Abulimiti M; Tan Y; Deng F; Huang W; Zou S; Kang W; Jiang L; Wang Y; Hu C; Chen Y; Zhou H; Tang Y; Jin J
BMC Cancer; 2024 Apr; 24(1):501. PubMed ID: 38641773
[TBL] [Abstract] [Full Text] [Related]
9. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
[TBL] [Abstract] [Full Text] [Related]
10. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS.
Liang Y; Liu Z; Zuo D; Chen S; Chen J; Yan X; Liu P; Wang Q
Talanta; 2024 Jul; 274():126056. PubMed ID: 38599123
[TBL] [Abstract] [Full Text] [Related]
11. Management and staging of anal adenocarcinoma in the United States: a population-based analysis.
Troester A; Kohn J; Wang Q; Weaver L; Hassan I; Gaertner W; Marmor S; Goffredo P
J Gastrointest Surg; 2024 Apr; 28(4):519-527. PubMed ID: 38583905
[TBL] [Abstract] [Full Text] [Related]
12. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
[TBL] [Abstract] [Full Text] [Related]
14. Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study.
Matsubara D; Soga K; Ikeda J; Kumano T; Mitsuda M; Konishi T; Komatsu S; Shimomura K; Taniguchi F; Shioaki Y; Otsuji E
BMC Gastroenterol; 2024 Apr; 24(1):125. PubMed ID: 38566007
[TBL] [Abstract] [Full Text] [Related]
15. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
[TBL] [Abstract] [Full Text] [Related]
16. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
17. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
Lee KH; Yang IJ; Ha GW; Lee J; Park YY; Lee SH; Lee JM; Bae JH; Park EJ; Kim H; Kim KY; An S; Kim IY; Kim JY
BMC Cancer; 2024 Mar; 24(1):397. PubMed ID: 38553680
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
[TBL] [Abstract] [Full Text] [Related]
19. High-risk Patients With colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
[TBL] [Abstract] [Full Text] [Related]
20. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis.
Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R
Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824
[TBL] [Abstract] [Full Text] [Related]
[Next]
